1Calcutt NA,Campana WM,Eskeland NL,et al.Prosaposin gene expression and the efficacy of a prosaposin derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats [J].J Neuropathol Exp Neurol,1999,58:628.
2Cotter MA,Cameron NE.Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alphal-adrenoceptor antagonist treatment:interactions with the nitric oxide system[J].European J Pharmacology,1998,343:217.
3Veves A,Akbari CM,Privavera J,et al.Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration[J].Diabetes,1998,47:457.
4Luo ZD,Chaplan SR,Scott BP,et al.Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation:lack of a role in allodynia development[J].J Neurosci,1999,19:9201.
5Grover VS, Sharma A,Singh M.Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice[J].European Journal of Pharmacology,2000,399:161.
6Russell JW,Feldman EL. Znsulin-like growth factor-1 prevents apoptosis in sympathetic neurons exposed to high glucose[J].Horm Metab Res,1999,31:90.
7Vinik AI.Diabetic neuropathy:pathogenesis and therapy[J].Am J Med,1999,107:17.
8Klemm T,Paschke R.Possible genetic causes for late complications of diabetes mellitus[J].Med Klin,2000,95:31.
9Ohsawa M,Kashiwazaki T,Kamei J.Modulation of the formalin induced nociceptive response by diabetes:possible involvement of protein kinasec[J].Brain Res,1998,803:198.
10Urban PP,Forst T,Lenfers M,et al.Incidence of subclinical trgeminal and facial nerve involvement in diabetes mellitus[J].Electromyogr Clin Neurophysiol,1999,39:267.
